2seventy bio Inc. (TSVT)

AI Score

Unlock

4.93

0.04 (0.82%)

At close: Apr 09, 2025, 3:59 PM

4.93

0.03%

After-hours: Apr 09, 2025, 06:05 PM EDT

Dividends

No dividend history available for 2seventy bio Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

TSVT News

2 weeks ago · 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results - businesswire.com
3 weeks ago · 2seventy bio, Inc. (TSVT) Upgraded to Buy: Here's Why - zacks.com
3 weeks ago · 2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT - businesswire.com
4 weeks ago · Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders - businesswire.com
1 month ago · TSVT Up on Acquisition Agreement With BMY for $286 Million - zacks.com
4 weeks ago · Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal - benzinga.com
4 weeks ago · Top 3 Health Care Stocks That May Keep You Up At Night In Q1 - benzinga.com
4 weeks ago · Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million - reuters.com
1 month ago · 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - businesswire.com
2 months ago · 2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - businesswire.com